0001209191-20-006956.txt : 20200205
0001209191-20-006956.hdr.sgml : 20200205
20200205165134
ACCESSION NUMBER: 0001209191-20-006956
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200203
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20579479
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-02-03
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Patient Officer
Common Stock
2020-02-03
4
M
0
2156
91.05
A
38346
D
Common Stock
2020-02-03
4
M
0
1941
86.52
A
40287
D
Common Stock
2020-02-03
4
S
0
500
228.89
D
39787
D
Common Stock
2020-02-03
4
S
0
714
230.07
D
39073
D
Common Stock
2020-02-03
4
S
0
1306
231.25
D
37767
D
Common Stock
2020-02-03
4
S
0
1177
231.92
D
36590
D
Common Stock
2020-02-03
4
S
0
400
232.87
D
36190
D
Common Stock
882
I
401(k)
Common Stock
16190
I
Held in trust
Stock Option (Right to Buy)
91.05
2020-02-03
4
M
0
2156
0.00
D
2026-02-01
Common Stock
2156
0
D
Stock Option (Right to Buy)
86.52
2020-02-03
4
M
0
1941
0.00
D
2027-02-02
Common Stock
1941
7767
D
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $228.89 (range $228.37 to $229.12).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $230.07 (range $229.48 to $230.47).
Open market sales reported on this line occurred at a weighted average price of $231.25 (range $230.53 to $231.50).
Open market sales reported on this line occurred at a weighted average price of $231.92 (range $231.54 to $232.50).
Open market sales reported on this line occurred at a weighted average price of $232.87 (range $232.67 to $233.31).
Fully vested.
The option vests in 16 quarterly installments from 02/03/2017.
/s/ Omar White, Attorney-in-Fact
2020-02-05